Literature DB >> 33680918

Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes.

Heather Fairfield1,2,3, Samantha Costa1,2,3, Carolyne Falank1,2,3, Mariah Farrell1,2,4, Connor S Murphy1,2,3, Anastasia D'Amico1,2,4, Heather Driscoll5, Michaela R Reagan1,2,3,4.   

Abstract

Within the bone marrow microenvironment, mesenchymal stromal cells (MSCs) are an essential precursor to bone marrow adipocytes and osteoblasts. The balance between this progenitor pool and mature cells (adipocytes and osteoblasts) is often skewed by disease and aging. In multiple myeloma (MM), a cancer of the plasma cell that predominantly grows within the bone marrow, as well as other cancers, MSCs, preadipocytes, and adipocytes have been shown to directly support tumor cell survival and proliferation. Increasing evidence supports the idea that MM-associated MSCs are distinct from healthy MSCs, and their gene expression profiles may be predictive of myeloma patient outcomes. Here we directly investigate how MM cells affect the differentiation capacity and gene expression profiles of preadipocytes and bone marrow MSCs. Our studies reveal that MM.1S cells cause a marked decrease in lipid accumulation in differentiating 3T3-L1 cells. Also, MM.1S cells or MM.1S-conditioned media altered gene expression profiles of both 3T3-L1 and mouse bone marrow MSCs. 3T3-L1 cells exposed to MM.1S cells before adipogenic differentiation displayed gene expression changes leading to significantly altered pathways involved in steroid biosynthesis, the cell cycle, and metabolism (oxidative phosphorylation and glycolysis) after adipogenesis. MM.1S cells induced a marked increase in 3T3-L1 expression of MM-supportive genes including Il-6 and Cxcl12 (SDF1), which was confirmed in mouse MSCs by qRT-PCR, suggesting a forward-feedback mechanism. In vitro experiments revealed that indirect MM exposure prior to differentiation drives a senescent-like phenotype in differentiating MSCs, and this trend was confirmed in MM-associated MSCs compared to MSCs from normal donors. In direct co-culture, human mesenchymal stem cells (hMSCs) exposed to MM.1S, RPMI-8226, and OPM-2 prior to and during differentiation, exhibited different levels of lipid accumulation as well as secreted cytokines. Combined, our results suggest that MM cells can inhibit adipogenic differentiation while stimulating expression of the senescence associated secretory phenotype (SASP) and other pro-myeloma molecules. This study provides insight into a novel way in which MM cells manipulate their microenvironment by altering the expression of supportive cytokines and skewing the cellular diversity of the marrow.
Copyright © 2021 Fairfield, Costa, Falank, Farrell, Murphy, D’Amico, Driscoll and Reagan.

Entities:  

Keywords:  adipocytes; bone marrow; mesenchymal stromal cells (MSCs); microarray; myeloma; preadipocytes ; senescence

Year:  2021        PMID: 33680918      PMCID: PMC7930573          DOI: 10.3389/fonc.2020.584683

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   5.738


  63 in total

Review 1.  Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.

Authors:  Roland Baron; Georges Rawadi
Journal:  Endocrinology       Date:  2007-03-29       Impact factor: 4.736

2.  Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.

Authors:  Syed J Mehdi; Sarah K Johnson; Joshua Epstein; Maurizio Zangari; Pingping Qu; Antje Hoering; Frits van Rhee; Carolina Schinke; Sharmilan Thanendrarajan; Bart Barlogie; Faith E Davies; Gareth J Morgan; Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2018-11-08       Impact factor: 6.998

3.  Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.

Authors:  Eric A Ariazi; Heather E Cunliffe; Joan S Lewis-Wambi; Michael J Slifker; Amanda L Willis; Pilar Ramos; Coya Tapia; Helen R Kim; Smitha Yerrum; Catherine G N Sharma; Emmanuelle Nicolas; Yoganand Balagurunathan; Eric A Ross; V Craig Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

4.  Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells.

Authors:  Ping Fan; Doris R Siwak; Balkees Abderrahman; Fadeke A Agboke; Smitha Yerrum; V Craig Jordan
Journal:  Mol Cancer Ther       Date:  2019-09-11       Impact factor: 6.261

Review 5.  Cellular senescence and tumor suppressor gene p16.

Authors:  Hani Rayess; Marilene B Wang; Eri S Srivatsan
Journal:  Int J Cancer       Date:  2011-12-05       Impact factor: 7.396

6.  PPAR{gamma} accelerates cellular senescence by inducing p16INK4{alpha} expression in human diploid fibroblasts.

Authors:  Qini Gan; Jing Huang; Rui Zhou; Jing Niu; Xiaojun Zhu; Jing Wang; Zongyu Zhang; Tanjun Tong
Journal:  J Cell Sci       Date:  2008-06-10       Impact factor: 5.285

7.  Semaphorin-3A inhibits multiple myeloma progression in a mouse model.

Authors:  Noa Lavi; Ofra Kessler; Keren Ziv; Inbal Nir-Zvi; Yelena Mumblat; Nasrene Eiza; Yael Paran; Benjamin Brenner; Zahava Vadasz; Gera Neufeld
Journal:  Carcinogenesis       Date:  2018-10-08       Impact factor: 4.944

8.  Adipocytes contribute to the growth and progression of multiple myeloma: Unraveling obesity related differences in adipocyte signaling.

Authors:  Erica M Bullwinkle; Melissa D Parker; Nicole F Bonan; Lauren G Falkenberg; Steven P Davison; Kathleen L DeCicco-Skinner
Journal:  Cancer Lett       Date:  2016-06-16       Impact factor: 8.679

9.  Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow.

Authors:  Bo O Zhou; Rui Yue; Malea M Murphy; James G Peyer; Sean J Morrison
Journal:  Cell Stem Cell       Date:  2014-06-19       Impact factor: 24.633

10.  Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation.

Authors:  Zhiqiang Liu; Jingda Xu; Jin He; Huan Liu; Pei Lin; Xinhai Wan; Nora M Navone; Qiang Tong; Larry W Kwak; Robert Z Orlowski; Jing Yang
Journal:  Oncotarget       Date:  2015-10-27
View more
  6 in total

1.  Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies.

Authors:  Rui Liu; Dandan Gao; Yang Lv; Meng Zhai; Aili He
Journal:  BMC Endocr Disord       Date:  2022-01-25       Impact factor: 2.763

Review 2.  Natural Killer Cells in the Malignant Niche of Multiple Myeloma.

Authors:  Ondrej Venglar; Julio Rodriguez Bago; Benjamin Motais; Roman Hajek; Tomas Jelinek
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

Review 3.  Metabolic Disorders in Multiple Myeloma.

Authors:  Maria Gavriatopoulou; Stavroula A Paschou; Ioannis Ntanasis-Stathopoulos; Meletios A Dimopoulos
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

Review 4.  Multiple myeloma metabolism - a treasure trove of therapeutic targets?

Authors:  Monica Roman-Trufero; Holger W Auner; Claire M Edwards
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

Review 5.  Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma.

Authors:  Inge Oudaert; Arne Van der Vreken; Anke Maes; Elke De Bruyne; Kim De Veirman; Karin Vanderkerken; Eline Menu
Journal:  Exp Hematol Oncol       Date:  2022-09-01

6.  Report From the 6th International Meeting on Bone Marrow Adiposity (BMA2020).

Authors:  Erica L Scheller; Meghan E McGee-Lawrence; Beata Lecka-Czernik
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.